Literature DB >> 1281177

Mast cells and eosinophils in the allergic mucosal response to allergen challenge: changes in distribution and signs of activation in relation to symptoms.

S Juliusson1, U Pipkorn, G Karlsson, L Enerbäck.   

Abstract

An allergen challenge was performed in 10 asymptomatic patients with strictly seasonal allergic rhinitis. For comparison; seven nonallergic subjects were challenged with allergen, and seven allergic patients were challenged with diluent. Cell samples, obtained with use of a brush technique to recover cells from within the epithelium and nasal lavage to collect cells from the epithelial surface, and symptom scores were taken before challenge and at 2-hour intervals during 12 hours. The cell suspensions were cytocentrifuged onto object slides for light microscopy. Histamine was determined in the cell pellets. In brush samples from the allergic patients challenged with allergen, eosinophils, expressed as a percentage of the total granulocytes, increased from 4.3% +/- 2.7% (mean +/- SEM) to 10.3% +/- 3.8% (p < 0.05) 4 hours after challenge. This level was maintained for up to 12 hours. A similar increase was noted in the lavage specimens 2, 6, and 8 hours after the challenge. In the brush samples the proportion of eosinophils containing two or more cytoplasmic vacuoles, taken as a sign of activation, increased from 20% to 72% (p < 0.05) 8 hours after provocation. In brush samples from the allergic patients challenged with allergen, the numbers of metachromatic cells increased to a maximum of eightfold at 10 hours. In the lavage specimens, no metachromatic cells were observed before provocation, but they progressively increased in number 2 to 12 hours after provocation. Cell pellet histamine content decreased temporarily 2 to 4 hours after challenge (p < 0.05) in brush samples from allergen-challenged allergic patients. The local metachromatic cell density before challenge, as reflected in the brush specimens, correlated with nasal congestion, sneezing, and the degree of eosinophilia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281177     DOI: 10.1016/0091-6749(92)90462-b

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  11 in total

1.  Diagnostic tools in Rhinology EAACI position paper.

Authors:  Glenis Scadding; Peter Hellings; Isam Alobid; Claus Bachert; Wytske Fokkens; Roy Gerth van Wijk; Philippe Gevaert; Josep Guilemany; Livije Kalogjera; Valerie Lund; Joaquim Mullol; Giovanni Passalacqua; Elina Toskala; Cornelius van Drunen
Journal:  Clin Transl Allergy       Date:  2011-06-10       Impact factor: 5.871

2.  Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps.

Authors:  Tetsuji Takabayashi; Atsushi Kato; Anju T Peters; Lydia A Suh; Roderick Carter; James Norton; Leslie C Grammer; Bruce K Tan; Rakesh K Chandra; David B Conley; Robert C Kern; Shigeharu Fujieda; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2012-04-24       Impact factor: 10.793

Review 3.  Resolution of leucocyte-mediated mucosal diseases. A novel in vivo paradigm for drug development.

Authors:  Carl Persson; Lena Uller
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 4.  Resolution of cell-mediated airways diseases.

Authors:  Carl G Persson; Lena Uller
Journal:  Respir Res       Date:  2010-06-11

5.  Characterisation of immune mediator release during the immediate response to segmental mucosal challenge in the jejunum of patients with food allergy.

Authors:  J Santos; C Bayarri; E Saperas; C Nogueiras; M Antolín; M Mourelle; A Cadahia; J R Malagelada
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

6.  Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell.

Authors:  Carole A Oskeritzian; Wei Zhao; Hae-Ki Min; Han-Zhang Xia; Andrea Pozez; Jonathan Kiev; Lawrence B Schwartz
Journal:  J Allergy Clin Immunol       Date:  2005-06       Impact factor: 10.793

Review 7.  Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies.

Authors:  G W Canonica; E Compalati
Journal:  Clin Exp Immunol       Date:  2009-08-25       Impact factor: 4.330

Review 8.  Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a.

Authors:  Hydar Ali
Journal:  Immunol Lett       Date:  2009-11-04       Impact factor: 3.685

9.  Inflammatory patterns of allergic and nonallergic rhinitis.

Authors:  S E Sobol; P Christodoulopoulos; Q A Hamid
Journal:  Curr Allergy Asthma Rep       Date:  2001-05       Impact factor: 4.919

Review 10.  Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis.

Authors:  M Peters-Golden; M M Gleason; A Togias
Journal:  Clin Exp Allergy       Date:  2006-06       Impact factor: 5.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.